| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 12/18/2013 | CN102732510B Method for simultaneously removing bacillus anthracis virulence megaplasmids pXO1 and pXO2 |
| 12/18/2013 | CN102671011B Traditional Chinese medicine compound powder for preventing and treating yellow and white scour of piglets and preparation method thereof |
| 12/18/2013 | CN102670937B Traditional Chinese medicine composition for treating disease of swine fever |
| 12/18/2013 | CN102631427B Traditional Chinese medicine for preventing and treating livestock immunosuppressive diseases and preparation method thereof |
| 12/18/2013 | CN102600250B In-situ gel sustained-release preparation of Ranunculus ternatus Thunb., and its preparation method |
| 12/18/2013 | CN102579991B Traditional Chinese medicine composition for treating herpes simplex viral keratitis |
| 12/18/2013 | CN102579543B Method for extracting Traditional Chinese medicine active ingredients of marigold inflorescences |
| 12/18/2013 | CN102526718B Recombinant H5N1 (Hemagglutinin 5 Neuraminidase 1) avian influenza virus cell vaccine and application thereof |
| 12/18/2013 | CN102516242B Berberine azole compound and preparation method and application thereof |
| 12/18/2013 | CN102488754B Fishing traditional Chinese medicine composition capable of inhibiting germs and preparation method thereof |
| 12/18/2013 | CN102488753B Fishing Chinese medicinal composition with antibacterial and antibiotic functions and preparation method thereof |
| 12/18/2013 | CN102429904B Application of (RS)-2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazole-1-radical)-hexyl-2-alcohol to preparation of silkworm medicament |
| 12/18/2013 | CN102397385B Injection prepared from heartleaf houttuynia herb and preparation method thereof |
| 12/18/2013 | CN102382176B Oral cavity cariogenic bacterium-resisting polypeptide Pm11 and preparation method thereof |
| 12/18/2013 | CN102351927B Borojo active extract and preparation method and antibacterial and anti-oxidation application thereof |
| 12/18/2013 | CN102286072B Staphylococcus aureus AgrC group induction system resistant auto-induced peptide (AIP) polypeptide derivatives and use thereof |
| 12/18/2013 | CN102276730B Preparation method for staphylococcus aureus Iron-regulated surface determinant B immunodominant fragment (IsdBid)-target of RNAIII activating protein (TRAP) fusion protein and application thereof |
| 12/18/2013 | CN102219815B Six tiacumicins compounds, preparation method and use of six tiacumicins compounds in preparing antibacterial drugs |
| 12/18/2013 | CN102205117B Dairy cow mammitis staphylococcus aureus-Escherichia coli bigeminy polyvalent vaccine and preparation method thereof |
| 12/18/2013 | CN102140441B Bird flu vaccine by using attenuated vaccinia Tian Tan as vector |
| 12/18/2013 | CN101489557B Co-crystals comprising VX-950 and pharmaceutical compositions comprising same |
| 12/17/2013 | US8609725 Method of using beta-hydroxy-beta-methylbutyrate for reducing tumor growth rate |
| 12/17/2013 | US8609668 Substituted triazolo[1,5-A]pyrimidines as antiviral agents |
| 12/17/2013 | US8609653 Azaindole compounds and methods for treating HIV |
| 12/17/2013 | US8609135 Anthracycline derivatives |
| 12/17/2013 | CA2774250C C-linked hydroxamic acid derivatives useful as antibacterial agents |
| 12/17/2013 | CA2637388C Pyrrolopyridazinone compound |
| 12/17/2013 | CA2508228C Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
| 12/17/2013 | CA2492598C Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 12/17/2013 | CA2410883C Methods for isolating and using fungal hemolysins |
| 12/17/2013 | CA2395423C P. gingivalis antigenic composition |
| 12/17/2013 | CA2370563C Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein |
| 12/12/2013 | WO2013185124A1 Antimicrobial compounds, compositions and methods of use thereof |
| 12/12/2013 | WO2013185103A1 Macrocyclic inhibitors of flaviviridae viruses |
| 12/12/2013 | WO2013185093A1 Macrocyclic inhibitors of flaviviridae viruses |
| 12/12/2013 | WO2013185090A1 Macrocyclic inhibitors of flaviviridae viruses |
| 12/12/2013 | WO2013184845A1 Cyclic boronic acid ester derivatives and therapeutic uses thereof |
| 12/12/2013 | WO2013184806A1 Inhibitors of respiratory syncytial virus |
| 12/12/2013 | WO2013184780A1 Novel iminosugars and their applications |
| 12/12/2013 | WO2013184698A1 Solid forms of an antiviral compound |
| 12/12/2013 | WO2013182254A1 Pyrrolyl-hydroxamates for use in the prevention and/or treatment of bacterial infections |
| 12/12/2013 | WO2013182070A1 Drug for preventing or treating mycobacterial diseases |
| 12/12/2013 | WO2013181696A1 Vaccination with interleukin-4 antagonists |
| 12/12/2013 | WO2013181694A1 Compositions and methods for treating crohn's disease and related conditions and infections |
| 12/12/2013 | WO2013135395A8 Composition comprising arabinogalactan and polyphenols from larch trees |
| 12/12/2013 | US20130331310 Prodrug of an Ice Inhibitor |
| 12/12/2013 | US20130330363 Method of vaccination |
| 12/12/2013 | US20130330357 METHODS OF TREATING DISORDERS USING HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 12/12/2013 | US20130330356 METHODS OF TREATING DISORDERS USING HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 12/12/2013 | US20130330342 Antibody fragments inhibiting hiv nef protein |
| 12/12/2013 | US20130330332 Treatment of pemphigus |
| 12/12/2013 | DE202013009988U1 Biologischer antimykotischer Nagellack, Nagellasur, und/oder Nagelhärter Biological antifungal nail polish, nail varnish, and / or nail hardener |
| 12/12/2013 | CA2875975A1 Novel iminosugars and their applications |
| 12/12/2013 | CA2875718A1 Macrocyclic inhibitors of flaviviridae viruses |
| 12/12/2013 | CA2875692A1 Macrocyclic inhibitors of flaviviridae viruses |
| 12/12/2013 | CA2875690A1 Macrocyclic inhibitors of flaviviridae viruses |
| 12/12/2013 | CA2875683A1 Vaccination with interleukin-4 antagonists |
| 12/12/2013 | CA2875681A1 Compositions and methods for treating crohn's disease and related conditions and infections |
| 12/12/2013 | CA2875507A1 Solid forms of an antiviral compound |
| 12/11/2013 | EP2671952A1 Method for preparing cyclic lipopeptide compound |
| 12/11/2013 | EP2671888A1 3',5'-cyclic nucleoside phosphate analogues |
| 12/11/2013 | EP2671887A1 Novel macrolide derivative |
| 12/11/2013 | EP2671640A1 Copper-and-titanium-containing composition and production method therefor |
| 12/11/2013 | EP2670765A1 C-17 and c-3 modified triterpenoids with hiv maturation inhibitory activity |
| 12/11/2013 | EP2670764A1 C-28 amines of c-3 modified betulinic acid derivatives as hiv maturation inhibitors |
| 12/11/2013 | EP2670422A1 Antagonism of the vip signaling pathway |
| 12/11/2013 | EP2670420A1 Antiviral agent containing recombinant mistletoe lectins |
| 12/11/2013 | EP2670417A1 Methods and compositions for treating bacterial infections with iron chelators |
| 12/11/2013 | EP2670410A1 Antimicrobial 4-oxoquinolizines |
| 12/11/2013 | EP2670407A2 Treatment of bacterial infections |
| 12/11/2013 | EP2670404A1 Sirtuin modulators as virus production modulators |
| 12/11/2013 | CN103443269A Bacteriophage lytic enzymes as alternative antimicrobials |
| 12/11/2013 | CN103443098A Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof |
| 12/11/2013 | CN103443096A Pyrimidine gyrase and topoisomerase iv inhibitors |
| 12/11/2013 | CN103443079A Fluoro-pyridinone derivatives useful as antibacterial agents |
| 12/11/2013 | CN103442731A Expression systems |
| 12/11/2013 | CN103442728A Antibacterial agent for treating infectious diseases of bacterial origin |
| 12/11/2013 | CN103442713A Pharmaceutical formulation for topical administration comprising B220 |
| 12/11/2013 | CN103442694A Microparticle formulation for pulmonary drug delivery of anti-nfective molecule for treatment of infectious diseases |
| 12/11/2013 | CN103436555A Construction method and application of adipose-derived mesenchymal stem cells (AMSC) carrying miR-122 |
| 12/11/2013 | CN103436553A Method for preparing recombinant coxsackievirus A16 type virus-like particles |
| 12/11/2013 | CN103436507A Phage derived antimicrobial activities |
| 12/11/2013 | CN103436499A Porcine circovirus-like particle, and vaccine and preparation method thereof |
| 12/11/2013 | CN103436478A Salmonella enteritidis double knockout attenuated mutant and preparation as well as application thereof |
| 12/11/2013 | CN103436461A Novel lactic acid bacteria and immune reaction regulation uses thereof |
| 12/11/2013 | CN103436458A Streptomyces, spiroteteronate compound produced by streptomyces, and preparation method and application of spiroteteronate compound |
| 12/11/2013 | CN103436364A Preparation method and application of dracocephalum heterophyllum benth volatile oil |
| 12/11/2013 | CN103435701A Pig antibacterial peptide cystatin11 fusion protein, and encoding gene and application thereof |
| 12/11/2013 | CN103435697A Neutralizing antibodies to influenza viruses |
| 12/11/2013 | CN103435690A DNA (deoxyribonucleic acid) vaccine of HCV (hepatitis C virus) and preparation method thereof |
| 12/11/2013 | CN103435686A Polypeptide Cbf-14 resisting infection of drug-resistant bacteria and application thereof |
| 12/11/2013 | CN103435678A Preparation method of maslinic acid and application of maslinic acid in preparation of antibacterial agent |
| 12/11/2013 | CN103435672A Structure and synthesis of novel nucleoside phosphate prodrug containing substituted benzyl |
| 12/11/2013 | CN103435650A Novel monocycle beta-lactam compounds, preparation method and pharmaceutical application for same |
| 12/11/2013 | CN103435639A Axial nucleoside asymmetrically-modified silicon phthalocyanine and preparation method and application thereof |
| 12/11/2013 | CN103435622A Spiro indole diketopiperazine alkaloid, and synthesis method and application of spiro indole diketopiperazine alkaloid |
| 12/11/2013 | CN103435621A Spiro quinazoline derivative and preparation method thereof |
| 12/11/2013 | CN103435611A Multi-target point alpha-pyridoin compounds and preparation method and application thereof |
| 12/11/2013 | CN103435601A Multiple-target-point flavone-quinolinone compound and preparation method and applications thereof |
| 12/11/2013 | CN103435600A Alkyl connection quinolinone-furanone compounds and preparation method and application thereof |